Context Capital Management, LLC - Q2 2018 holdings

$116 Million is the total value of Context Capital Management, LLC's 48 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 112.5% .

 Value Shares↓ Weighting
BuyAMAG PHARMACEUTICALS INCnote 3.250% 6/0$9,006,000
+15.4%
8,800,000
+16.6%
7.74%
+36.7%
BuyTHERAVANCE BIOPHARMA INCnote 3.250%11/0$5,466,000
+53.2%
5,500,000
+57.1%
4.70%
+81.5%
BuyVECTOR GROUP LTDfrnt$5,281,000
+220.3%
5,000,000
+233.3%
4.54%
+279.4%
NewMICROCHIP TECHNOLOGY INCnote 2.250% 2/1$5,247,0004,400,000
+100.0%
4.51%
BuyDEPOMED INCnote 2.500% 9/0$4,514,000
+22.3%
5,500,000
+22.2%
3.88%
+44.9%
BuyMEDICINES COnote 2.750% 7/1$3,031,000
+530.1%
3,000,000
+500.0%
2.61%
+646.7%
BuyTESLA INCnote 2.375% 3/1$2,432,000
+365.0%
2,000,000
+300.0%
2.09%
+450.3%
LQD BuyISHARES TRiboxx inv cp etf$2,406,000
+46.4%
21,000
+50.0%
2.07%
+73.6%
NewDERMIRA INCnote 3.000% 5/1$2,085,0002,525,000
+100.0%
1.79%
LFACU NewLF CAP ACQUISITION CORPunit 06/19/2025$2,016,000200,190
+100.0%
1.73%
NewCHART INDS INCnote 2.000% 8/0$1,898,0001,874,000
+100.0%
1.63%
MUDSU BuyMUDRICK CAP ACQUISITION CORPunit 02/01/2023$1,456,000
+42.5%
140,000
+40.0%
1.25%
+68.7%
TMCXU NewTRINITY MERGER CORPunit 05/11/2025$1,226,000121,868
+100.0%
1.05%
NewROVI CORPnote 0.500% 3/0$954,0001,000,000
+100.0%
0.82%
NewCALAMP CORPnote 1.625% 5/1$954,000893,000
+100.0%
0.82%
NewCLOVIS ONCOLOGY INCnote 1.250% 5/0$924,0001,000,000
+100.0%
0.79%
NewINTERCEPT PHARMACEUTICALS INnote 3.250% 7/0$484,0005,500,000
+100.0%
0.42%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
THERAVANCE BIOPHARMA INC23Q2 20224.7%
ENCORE CAPITAL GROUP INC19Q2 20196.2%
INTERCEPT PHARMACEUTICALS IN18Q4 20226.2%
INFINERA CORPORATION18Q1 20233.6%
TESLA MTRS INC16Q1 20194.9%
DISH NETWORK CORPORATION16Q3 20233.3%
ENDOLOGIX INC15Q2 201911.6%
OMEROS CORP15Q3 20233.1%
VANGUARD TOTAL STOCK MKT ETF15Q1 20203.9%
AMAG PHARMACEUTICALS INC14Q3 20207.7%

View Context Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Context Capital Management, LLC Q2 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ELECTRO ENERGY INCFebruary 17, 2009326,1244.9%
IRONCLAD PERFORMANCE WEAR CORPSold outFebruary 17, 200900.0%
Jazz Technologies, Inc.Sold outFebruary 17, 200900.0%
VELOCITY EXPRESS CORPFebruary 17, 2009190,1045.3%
ATS CORPJune 17, 2008723,0733.6%
Ascend Acquisition Corp.Sold outJune 16, 200800.0%
HIGHBURY FINANCIAL INCSold outJune 16, 200800.0%
PRIMUS TELECOMMUNICATIONS GROUP INCSold outJune 16, 200800.0%
Good Harbor Partners Acquisition CorpSold outFebruary 13, 200800.0%
InfuSystem Holdings, IncFebruary 13, 2008152,3500.8%

View Context Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-02
SCHEDULE 13G2024-03-20
13F-HR/A2024-02-16
13F-HR2024-02-09
13F-HR2023-11-13
13F-HR2023-08-10
13F-HR2023-05-08
13F-HR2023-02-14
13F-HR2022-11-07
13F-HR2022-08-03

View Context Capital Management, LLC's complete filings history.

Compare quarters

Export Context Capital Management, LLC's holdings